Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P06132: Variant p.Leu161Gln

Uroporphyrinogen decarboxylase
Gene: UROD
Feedback?
Variant information Variant position: help 161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Glutamine (Q) at position 161 (L161Q, p.Leu161Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (L) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In FPCT. Any additional useful information about the variant.


Sequence information Variant position: help 161 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 367 The length of the canonical sequence.
Location on the sequence: help TRQRLAGRVPLIGFAGAPWT L MTYMVEGGGSSTMAQAKRWL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         TRQRLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMAQAKRWL

Mouse                         TRQRLAGRVPLIGFAGAPWTLMTYMVEGGSSSTMAQAKRWL

Sheep                         TRQQLAGRVPLIGFAGAPWTLMTYMVEGGGSSTMSQAKRWL

Zebrafish                     TRHKIEGKVPLIGFTGAPWTLMSYMIEGGGSATHSKAKRWL

Drosophila                    MRHKLEGRVPLIGFTGAPWTLMGYMIEGGGSKTMSKAKAWL

Slime mold                    TRKRLEGRVPLIGFTGAPWTLMTYCIEGSGGTTMSNSKSWL

Baker's yeast                 TRIKLDGEVPLFGFCGGPWTLMVYMTEGGGSRLFRFAKQWI

Fission yeast                 TREKLDGQVPLMGFSGAPWTIMAYMIEGGGSKTFAKAKSWL

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 367 Uroporphyrinogen decarboxylase
Binding site 164 – 164
Mutagenesis 164 – 164 Y -> F. 25-30% of wild-type activity.
Helix 158 – 167



Literature citations
Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
Cappellini M.D.; Martinez Di Montemuros F.; Tavazzi D.; Fargion S.; Pizzuti A.; Comino A.; Cainelli T.; Fiorelli G.;
Hum. Mutat. 17:350-350(2001)
Cited for: VARIANTS FPCT GLN-142; GLN-161; PHE-219 AND SER-235;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.